RENAISSANCE TECHNOLOGIES LLC
Position in BDTX — Black Diamond Therapeutics, Inc.
CIK 1037389
NEW YORK, NY
Position in BDTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,501,181
+$1,193,325 QoQ
Shares Held
1,643,747
+73.1% QoQ
Ownership
2.87%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BDTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,450,872,574 across 330 Biotechnology names. BDTX ranks #99 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,726,993 | $588,750,729 | |
| 2 | INCY |
Incyte Corp
|
3,651,532 | $343,682,191 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
5,682,783 | $229,072,982 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
421,688 | $188,300,559 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
819,374 | $154,902,654 | |
| 6 | GMAB |
Genmab A/S
|
4,414,550 | $118,442,376 | |
| 7 | INVA |
Innoviva, Inc.
|
4,055,632 | $94,496,225 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,036,495 | $64,988,236 |
All Filings in BDTX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,501,181 | 1,643,747 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,307,856 | 949,735 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,271,726 | 599,400 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $414,408 | 167,100 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $123,845 | 79,900 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,934,560 | 904,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,104,030 | 253,800 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,229,774 | 263,900 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,077,882 | 212,600 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,265,624 | 450,400 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $943,943 | 328,900 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,114,535 | 220,700 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $411,075 | 217,500 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $397,103 | 220,613 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $367,913 | 217,700 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $669,124 | 272,002 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $732,640 | 264,491 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,054,182 | 385,400 | Shares | Sole | 2022-02-11 | |
| 2021-03-31 | $451,236 | 18,600 | Shares | Sole | 2021-05-13 | |
| 2020-06-30 | $1,117,535 | 26,507 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||